Par Drugs And Chemicals Limited (NSE:PAR) — Market Cap & Net Worth
Market Cap & Net Worth: Par Drugs And Chemicals Limited (PAR)
Par Drugs And Chemicals Limited (NSE:PAR) has a market capitalization of $13.19 Million (Rs1.22 Billion) as of August 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #26311 globally and #1464 in its home market, demonstrating a 5.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Par Drugs And Chemicals Limited's stock price Rs99.09 by its total outstanding shares 12304636 (12.30 Million). See PAR capex reinvestment rate to understand how much of operating cash flow is reinvested back into capital assets.
Par Drugs And Chemicals Limited Market Cap History: 2019 to 2026
Par Drugs And Chemicals Limited's market capitalization history from 2019 to 2026. Data shows growth from $2.84 Million to $13.19 Million (22.20% CAGR).
Par Drugs And Chemicals Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Par Drugs And Chemicals Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Par Drugs And Chemicals Limited's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.10x
Par Drugs And Chemicals Limited's market cap is 0.10 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $2.84 Million | $455.97 Million | $24.19 Million | 0.01x | 0.12x |
| 2020 | $4.82 Million | $550.97 Million | $47.65 Million | 0.01x | 0.10x |
| 2021 | $26.78 Million | $598.80 Million | $116.11 Million | 0.04x | 0.23x |
| 2022 | $20.10 Million | $746.15 Million | $92.13 Million | 0.03x | 0.22x |
| 2023 | $28.70 Million | $950.95 Million | $113.34 Million | 0.03x | 0.25x |
| 2024 | $26.47 Million | $956.40 Million | $145.01 Million | 0.03x | 0.18x |
| 2025 | $13.47 Million | $1.01 Billion | $133.58 Million | 0.01x | 0.10x |
| 2026 | $13.19 Million | $1.04 Billion | $131.09 Million | 0.01x | 0.10x |
Competitor Companies of PAR by Market Capitalization
Companies near Par Drugs And Chemicals Limited in the global market cap rankings as of August 4, 2026.
Key companies related to Par Drugs And Chemicals Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #504 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #543 globally with a market cap of $49.47 Billion USD ( CN¥338.09 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #549 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #504 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #543 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $49.47 Billion | CN¥53.00 |
| #549 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.97 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.70 |
Par Drugs And Chemicals Limited Historical Marketcap From 2019 to 2026
Between 2019 and today, Par Drugs And Chemicals Limited's market cap moved from $2.84 Million to $ 13.19 Million, with a yearly change of 22.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs13.19 Million | -2.14% |
| 2025 | Rs13.47 Million | -49.09% |
| 2024 | Rs26.47 Million | -7.79% |
| 2023 | Rs28.70 Million | +42.80% |
| 2022 | Rs20.10 Million | -24.94% |
| 2021 | Rs26.78 Million | +455.28% |
| 2020 | Rs4.82 Million | +69.85% |
| 2019 | Rs2.84 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Par Drugs And Chemicals Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.19 Million USD |
| MoneyControl | $13.19 Million USD |
| MarketWatch | $13.19 Million USD |
| marketcap.company | $13.19 Million USD |
| Reuters | $13.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more